JESSICA L JONES

Allopathic & Osteopathic Physicians|Obstetrics & Gynecology MOBILE, AL NPI 1093005779

General Payments — all program years on this page

$2,619.76

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 153
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $398.56 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $398.5620

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $666.2144
2019 $276.9518
2020 $118.618
2021 $331.0316
2022 $360.7922
2023 $467.6125
2024 $398.5620

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1079859771 Northgate Technologies, Inc. $24.78 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080511104 Monaghan Medical Corporation $33.96 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089439123 Daiichi Sankyo Inc. $28.80 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139301766 Astellas Pharma US Inc $17.31 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139309934 Astellas Pharma US Inc $16.50 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139368237 Astellas Pharma US Inc $22.04 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139420687 Astellas Pharma US Inc $18.71 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141926104 Merck Sharp & Dohme LLC $18.67 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148870449 Sumitomo Pharma America, Inc. $14.59 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148870451 Sumitomo Pharma America, Inc. $19.36 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148870453 Sumitomo Pharma America, Inc. $19.57 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148870455 Sumitomo Pharma America, Inc. $16.25 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148870457 Sumitomo Pharma America, Inc. $18.37 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148870459 Sumitomo Pharma America, Inc. $16.91 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148870461 Sumitomo Pharma America, Inc. $15.70 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149996362 Exeltis, USA Inc. $15.73 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150151658 SHIELD THERAPEUTICS INC $21.86 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154713681 MAYNE PHARMA COMMERCIAL LLC $29.03 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154713683 MAYNE PHARMA COMMERCIAL LLC $2.74 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154713685 MAYNE PHARMA COMMERCIAL LLC $27.68 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.